tetano
Editor, Senior Moderator
QJM
. 2022 Oct 12;hcac234.
doi: 10.1093/qjmed/hcac234. Online ahead of print.
MIF is a Common Genetic Determinant of COVID-19 Symptomatic Infection and Severity
Junghee J Shin[SUP] 1 [/SUP], Wei Fan[SUP] 1 [/SUP], Jennefer Par-Young[SUP] 1 [/SUP], Marta Piecychna[SUP] 1 [/SUP], Lin Leng[SUP] 1 [/SUP], Kavita Israni-Winger[SUP] 2 [/SUP], Hua Qing[SUP] 2 [/SUP], Jianlei Gu[SUP] 3 [/SUP], Hongyu Zhao[SUP] 3 [/SUP], Wade L Schulz[SUP] 2 [/SUP], Serhan Unlu[SUP] 1 [/SUP], John Kuster[SUP] 1 [/SUP], Grant Young[SUP] 4 [/SUP], Jian Liu[SUP] 3 [/SUP], Albert I Ko[SUP] 3 [/SUP], Alvaro Baeza Garcia[SUP] 5 [/SUP], Maor Sauler[SUP] 6 [/SUP], Adam V Wisnewski[SUP] 7 [/SUP], Lawrence Young[SUP] 4 [/SUP], Antonio Orduña[SUP] 8 [/SUP], Andrew Wang[SUP] 1 2 [/SUP], Ocskay Klementina[SUP] 9 10 [/SUP], Antonio Blesa Garcia[SUP] 11 [/SUP], Peter Hegyi[SUP] 9 10 12 [/SUP], Michelle E Armstrong[SUP] 13 [/SUP], Patrick Mitchell[SUP] 13 [/SUP], David Bernardo Ordiz[SUP] 12 14 [/SUP], András Garami[SUP] 9 [/SUP], Insoo Kang[SUP] 1 [/SUP], Richard Bucala[SUP] 1 3 15 [/SUP]
Affiliations
Abstract
Background: Genetic predisposition to COVID-19 may contribute to its morbidity and mortality. Because cytokines play an important role in multiple phases of infection, we examined whether commonly occurring, functional polymorphisms in macrophage migration inhibitory factor (MIF) are associated with COVID-19 infection or disease severity.
Aim: To determine associations of common functional polymorphisms in MIF with symptomatic COVID-19 or its severity.
Methods: This retrospective case control study utilized 1171 patients with COVID-19 from three tertiary medical centers in the United States, Hungary, and Spain, together with a group of 637 pre-pandemic, healthy control subjects. Functional MIF promoter alleles (-794 CATT5-8, rs5844572), serum MIF and soluble MIF receptor levels, and available clinical characteristics were measured and correlated with COVID-19 diagnosis and hospitalization. Experimental mice genetically engineered to express human high- or low-expression MIF alleles were studied for response to coronavirus infection.
Results: In patients with COVID-19, there was a lower frequency of the high-expression MIF CATT7 allele when compared to healthy controls (11% vs. 19%, OR: 0.54 [0.41, 0.72], p < 0.0001). Among inpatients with COVID-19 (n = 805), there was a higher frequency of the MIF CATT7 allele compared to outpatients (n = 187) (12% vs. 5%, OR: 2.87 [1.42, 5.78], p = 0.002). Inpatients presented with higher serum MIF levels when compared to outpatients or uninfected healthy controls (87 ng/ml vs. 35 ng/ml vs. 29 ng/ml, p < 0.001, respectively). Among inpatients, circulating MIF concentrations correlated with admission ferritin (r = 0.19, p = 0.01) and maximum CRP (r = 0.16, p = 0.03) levels. Mice with a human high-expression MIF allele showed more severe disease than those with a low-expression MIF allele.
Conclusions: In this multinational retrospective study of 1171 subjects with COVID-19, the commonly occurring -794 CATT7 MIF allele is associated with reduced susceptibility to symptomatic SARS-CoV-2 infection but increased disease progression as assessed by hospitalization. These findings affirm the importance of host genetics in different stages of COVID-19 infection.
. 2022 Oct 12;hcac234.
doi: 10.1093/qjmed/hcac234. Online ahead of print.
MIF is a Common Genetic Determinant of COVID-19 Symptomatic Infection and Severity
Junghee J Shin[SUP] 1 [/SUP], Wei Fan[SUP] 1 [/SUP], Jennefer Par-Young[SUP] 1 [/SUP], Marta Piecychna[SUP] 1 [/SUP], Lin Leng[SUP] 1 [/SUP], Kavita Israni-Winger[SUP] 2 [/SUP], Hua Qing[SUP] 2 [/SUP], Jianlei Gu[SUP] 3 [/SUP], Hongyu Zhao[SUP] 3 [/SUP], Wade L Schulz[SUP] 2 [/SUP], Serhan Unlu[SUP] 1 [/SUP], John Kuster[SUP] 1 [/SUP], Grant Young[SUP] 4 [/SUP], Jian Liu[SUP] 3 [/SUP], Albert I Ko[SUP] 3 [/SUP], Alvaro Baeza Garcia[SUP] 5 [/SUP], Maor Sauler[SUP] 6 [/SUP], Adam V Wisnewski[SUP] 7 [/SUP], Lawrence Young[SUP] 4 [/SUP], Antonio Orduña[SUP] 8 [/SUP], Andrew Wang[SUP] 1 2 [/SUP], Ocskay Klementina[SUP] 9 10 [/SUP], Antonio Blesa Garcia[SUP] 11 [/SUP], Peter Hegyi[SUP] 9 10 12 [/SUP], Michelle E Armstrong[SUP] 13 [/SUP], Patrick Mitchell[SUP] 13 [/SUP], David Bernardo Ordiz[SUP] 12 14 [/SUP], András Garami[SUP] 9 [/SUP], Insoo Kang[SUP] 1 [/SUP], Richard Bucala[SUP] 1 3 15 [/SUP]
Affiliations
- PMID: 36222594
- DOI: 10.1093/qjmed/hcac234
Abstract
Background: Genetic predisposition to COVID-19 may contribute to its morbidity and mortality. Because cytokines play an important role in multiple phases of infection, we examined whether commonly occurring, functional polymorphisms in macrophage migration inhibitory factor (MIF) are associated with COVID-19 infection or disease severity.
Aim: To determine associations of common functional polymorphisms in MIF with symptomatic COVID-19 or its severity.
Methods: This retrospective case control study utilized 1171 patients with COVID-19 from three tertiary medical centers in the United States, Hungary, and Spain, together with a group of 637 pre-pandemic, healthy control subjects. Functional MIF promoter alleles (-794 CATT5-8, rs5844572), serum MIF and soluble MIF receptor levels, and available clinical characteristics were measured and correlated with COVID-19 diagnosis and hospitalization. Experimental mice genetically engineered to express human high- or low-expression MIF alleles were studied for response to coronavirus infection.
Results: In patients with COVID-19, there was a lower frequency of the high-expression MIF CATT7 allele when compared to healthy controls (11% vs. 19%, OR: 0.54 [0.41, 0.72], p < 0.0001). Among inpatients with COVID-19 (n = 805), there was a higher frequency of the MIF CATT7 allele compared to outpatients (n = 187) (12% vs. 5%, OR: 2.87 [1.42, 5.78], p = 0.002). Inpatients presented with higher serum MIF levels when compared to outpatients or uninfected healthy controls (87 ng/ml vs. 35 ng/ml vs. 29 ng/ml, p < 0.001, respectively). Among inpatients, circulating MIF concentrations correlated with admission ferritin (r = 0.19, p = 0.01) and maximum CRP (r = 0.16, p = 0.03) levels. Mice with a human high-expression MIF allele showed more severe disease than those with a low-expression MIF allele.
Conclusions: In this multinational retrospective study of 1171 subjects with COVID-19, the commonly occurring -794 CATT7 MIF allele is associated with reduced susceptibility to symptomatic SARS-CoV-2 infection but increased disease progression as assessed by hospitalization. These findings affirm the importance of host genetics in different stages of COVID-19 infection.